6-[(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBONYL)-AMINO]-HEXANOIC ACID
![]() |
- $378 - $874
- Product name: 6-[(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBONYL)-AMINO]-HEXANOIC ACID
- CAS: 313688-52-7
- MF: C15H19NO5
- MW: 293.32
- EINECS:
- MDL Number:MFCD01245239
- Synonyms:6-[(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBONYL)-AMINO]-HEXANOIC ACID;6-(2,3-Dihydrobenzo[b][1,4]dioxine-6-carboxamido)hexanoic acid;Hexanoic acid, 6-[[(2,3-dihydro-1,4-benzodioxin-6-yl)carbonyl]amino]-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0143127
- Product description6-[(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBONYL)AMINO]HEXANOIC ACID 95.00%
- Packaging500MG
- Price$772.7
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11147109
- Product description6-(2,3-Dihydrobenzo[b][1,4]dioxine-6-carboxamido)hexanoicacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number011761
- Product description6-[(2,3-Dihydro-benzo[1,4]dioxine-6-carbonyl)-amino]-hexanoic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0143127 | 6-[(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBONYL)AMINO]HEXANOIC ACID 95.00% | 500MG | $772.7 | 2021-12-16 | Buy |
Crysdot | CD11147109 | 6-(2,3-Dihydrobenzo[b][1,4]dioxine-6-carboxamido)hexanoicacid 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 011761 | 6-[(2,3-Dihydro-benzo[1,4]dioxine-6-carbonyl)-amino]-hexanoic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :497.9±45.0 °C(Predicted)
Density :1.243±0.06 g/cm3(Predicted)
pka :4.75±0.10(Predicted)
Density :1.243±0.06 g/cm3(Predicted)
pka :4.75±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|